Back to results
US 12,180,157 B2Granted
Crystalline bufotenidine compounds
AssigneeCaamtech, Inc.
InventorAndrew R Chadeayne
Life of this patent
Estimating the term…
Abstract
The disclosure relates to crystalline form 1 of 5-hydroxy-N,N,N-trimethyl-tryptammonium (5-HTQ) iodide, and to pharmaceutical compositions containing the compound and to methods of treatment using it.
Claims4
Crystalline form 1 of 5-hydroxy-N,N,N-trimethyl-tryptammonium (5-HTQ) iodide characterized by at least one of:
- an orthorhombic, P212121 crystal system space group at a temperature of about 297 K;
- unit cell dimensions a=8.9944 (4) Å, b=11.3250 (6) Å, and c=14.4042 (7) Å;
- an X-ray powder diffraction pattern characterized by at least two peaks selected from 14.0, 16.8, and 17.6°2θ±0.2°2θ;
- or
- an X-ray powder diffraction pattern substantially similar to FIG. 3.
2 more elements
Dependencies are inferred from the claim text.